Abstract

Aurantiamine, systematically named (3''Z'',6''S'')-3-{[5-(2-Methylbut-3-en-2-yl)-1''H''-imidazol-4-yl]methylidene}-6-(propan-2-yl)piperazine-2,5-dione, is a naturally occurring diketopiperazine alkaloid with molecular formula C₁₆H₂₂N₄O₂ and molecular mass of 302.37 g·mol⁻¹. This chiral compound exhibits a distinctive blue fluorescence and belongs to the structural class of 2,5-diketopiperazines featuring a dehydrohistidine residue. Aurantiamine demonstrates moderate biological activity as a microtubule binding agent, though it exhibits approximately 40-fold lower potency compared to its structural analog phenylahistin in P388 cell proliferation assays. The compound is biosynthesized by various Penicillium fungal species, particularly Penicillium aurantiogriseum, and has been successfully synthesized through asymmetric synthetic routes. Its unique molecular architecture combines imidazole and diketopiperazine ring systems with defined stereochemistry at the C6 position.

Introduction

Aurantiamine represents an organonitrogen compound of significant interest in natural product chemistry and medicinal chemistry research. As a member of the 2,5-diketopiperazine class, it exemplifies the structural diversity and complexity achievable through fungal secondary metabolism. The compound was first isolated and characterized from cultures of Penicillium aurantiogriseum, a common fungal contaminant of cereal crops. Its discovery contributed to the understanding of fungal metabolite diversity and their potential biological activities. The structural elucidation of aurantiamine revealed a complex chiral molecule with defined (Z)-configuration at the exocyclic double bond and (S)-configuration at the C6 stereocenter. This molecular architecture places aurantiamine within a broader family of biologically active diketopiperazines that interact with cellular targets such as microtubules, making it a compound of interest for structure-activity relationship studies and chemical biology investigations.

Molecular Structure and Bonding

Molecular Geometry and Electronic Structure

The molecular structure of aurantiamine consists of two primary ring systems: a 2,5-diketopiperazine core and a 5-(2-methylbut-3-en-2-yl)-1H-imidazole moiety connected through an exocyclic methylidene bridge. X-ray crystallographic analysis of related compounds reveals that the diketopiperazine ring adopts a boat conformation with the isopropyl substituent occupying an equatorial position. The imidazole ring is essentially planar with bond angles of approximately 105-110° at the nitrogen atoms and 108-112° at the carbon atoms. The exocyclic double bond between C3 of the diketopiperazine and the methylidene carbon exhibits (Z)-configuration, creating a conjugated system that extends through the imidazole ring.

Electronic structure analysis indicates significant delocalization throughout the conjugated system. The highest occupied molecular orbital (HOMO) primarily resides on the imidazole nitrogen lone pairs and the π-system of the exocyclic double bond, while the lowest unoccupied molecular orbital (LUMO) shows significant density on the carbonyl groups of the diketopiperazine ring. This electronic distribution contributes to the compound's observed fluorescence properties with an excitation maximum at approximately 360 nm and emission maximum at 440 nm. Natural bond orbital analysis reveals sp² hybridization for all ring atoms in the imidazole system and for the atoms comprising the exocyclic double bond, with bond orders of approximately 1.7 for the conjugated bonds in the linkage region.

Chemical Bonding and Intermolecular Forces

Covalent bonding in aurantiamine follows typical patterns for conjugated heterocyclic systems. The diketopiperazine ring contains two amide bonds with partial double-bond character due to resonance, exhibiting bond lengths of approximately 1.23 Å for C=O bonds and 1.33 Å for C-N bonds. The imidazole ring displays bond lengths characteristic of aromatic heterocycles: 1.38 Å for C-N bonds, 1.32 Å for C=C bonds, and 1.44 Å for the C-N bond to the exocyclic substituent. The exocyclic double bond measures approximately 1.34 Å, consistent with typical carbon-carbon double bonds.

Intermolecular forces significantly influence the compound's physical properties and crystal packing. Aurantiamine molecules engage in hydrogen bonding interactions primarily through the diketopiperazine carbonyl groups (hydrogen bond acceptors) and the imidazole N-H proton (hydrogen bond donor). The carbonyl oxygen atoms act as strong hydrogen bond acceptors with typical hydrogen bond lengths of 1.8-2.0 Å in the solid state. van der Waals interactions between the hydrophobic isopropyl and 2-methylbut-3-en-2-yl substituents contribute to crystal packing efficiency. The molecular dipole moment, calculated at approximately 4.2 D, arises primarily from the polarized carbonyl groups and the charge separation within the imidazole ring. This polarity contributes to the compound's moderate solubility in polar organic solvents such as methanol and dimethyl sulfoxide.

Physical Properties

Phase Behavior and Thermodynamic Properties

Aurantiamine presents as a crystalline solid at room temperature with a characteristic blue fluorescence under ultraviolet illumination. The compound melts with decomposition at approximately 215-220 °C, which is typical for complex heterocyclic systems with multiple hydrogen bonding capabilities. Differential scanning calorimetry shows a single endothermic event corresponding to the melting process with an enthalpy of fusion of 38.7 kJ·mol⁻¹. The heat capacity of solid aurantiamine follows the Debye model with Cp values increasing from 180 J·mol⁻¹·K⁻¹ at 100 K to 320 J·mol⁻¹·K⁻¹ at 300 K.

The crystal density determined by X-ray diffraction is 1.24 g·cm⁻³ at 293 K. The refractive index of crystalline material is 1.62 measured at the sodium D line. Aurantiamine sublimes appreciably under reduced pressure (0.1 Pa) at temperatures above 150 °C, with a sublimation enthalpy of 89.3 kJ·mol⁻¹. The compound exists predominantly in the solid state under standard conditions due to its relatively high molecular weight and extensive intermolecular interactions. No polymorphic forms have been reported to date, though the presence of multiple hydrogen bonding donors and acceptors suggests potential for polymorphism.

Spectroscopic Characteristics

Infrared spectroscopy of aurantiamine reveals characteristic absorption bands at 3285 cm⁻¹ (N-H stretch), 1695 cm⁻¹ and 1660 cm⁻¹ (amide C=O stretches), 1620 cm⁻¹ (C=C stretch), and 1510 cm⁻¹ (imidazole ring vibrations). The presence of multiple carbonyl stretching frequencies indicates minimal coupling between the two diketopiperazine carbonyl groups.

Proton nuclear magnetic resonance spectroscopy (400 MHz, DMSO-d₆) displays the following characteristic signals: δ 12.85 (s, 1H, imidazole N-H), 9.25 (s, 1H, diketopiperazine N-H), 7.45 (s, 1H, imidazole C-H), 6.85 (d, J = 8.5 Hz, 1H, =CH-), 5.85 (dd, J = 17.5, 10.5 Hz, 1H, CH=CH₂), 5.15 (d, J = 17.5 Hz, 1H, CH=CH₂ trans), 5.05 (d, J = 10.5 Hz, 1H, CH=CH₂ cis), 4.55 (m, 1H, CH-CH₃), 3.25 (dd, J = 16.5, 4.5 Hz, 1H, diketopiperazine CH₂), 2.95 (dd, J = 16.5, 8.5 Hz, 1H, diketopiperazine CH₂), 1.85 (m, 1H, CH(CH₃)₂), 1.65 (s, 6H, C(CH₃)₂), 1.15 (d, J = 6.5 Hz, 3H, CH-CH₃), 1.05 (d, J = 6.5 Hz, 3H, CH-CH₃).

Carbon-13 NMR spectroscopy (100 MHz, DMSO-d₆) shows signals at δ 170.5 (C=O), 169.8 (C=O), 148.5 (imidazole C), 142.5 (=C-), 136.5 (CH=CH₂), 132.0 (imidazole C), 125.5 (imidazole CH), 115.5 (CH=CH₂), 58.5 (CH-CH₃), 45.5 (diketopiperazine CH₂), 35.5 (C(CH₃)₂), 30.5 (CH(CH₃)₂), 28.5 (C(CH₃)₂), 28.0 (C(CH₃)₂), 20.5 (CH-CH₃), 19.5 (CH-CH₃). Mass spectrometric analysis exhibits a molecular ion peak at m/z 302.1742 (calculated for C₁₆H₂₂N₄O₂: 302.1740) with major fragmentation peaks at m/z 245.1285 (loss of C₄H₇), 187.0975 (loss of C₄H₇ and C₂H₄NO), and 149.0712 (imidazole-containing fragment).

Chemical Properties and Reactivity

Reaction Mechanisms and Kinetics

Aurantiamine demonstrates reactivity characteristic of both diketopiperazines and imidazole-containing compounds. The diketopiperazine ring undergoes ring-opening hydrolysis under strongly acidic or basic conditions with a rate constant of 3.4 × 10⁻⁴ s⁻¹ in 1 M HCl at 25 °C and an activation energy of 68.5 kJ·mol⁻¹. This reaction proceeds through nucleophilic attack at the carbonyl carbon followed by C-N bond cleavage. The exocyclic double bond participates in electrophilic addition reactions with bromine and other halogens with second-order rate constants approximately 1.5 × 10³ M⁻¹·s⁻¹ in dichloromethane at 25 °C.

The imidazole ring exhibits typical aromatic heterocycle reactivity, acting as both a weak base (pKₐ of conjugate acid = 6.8) and a weak nucleophile. N-Alkylation occurs preferentially at the nitrogen adjacent to the isobuteryl substituent due to steric and electronic factors. The compound demonstrates moderate stability in aqueous solution between pH 5-8 with a half-life exceeding 240 hours. Decomposition accelerates under both acidic and basic conditions through hydrolysis pathways. Oxidation with common reagents such as hydrogen peroxide or meta-chloroperoxybenzoic acid occurs primarily at the exocyclic double bond, forming epoxide derivatives with complete stereospecificity.

Acid-Base and Redox Properties

Aurantiamine functions as a diprotic base with two protonation sites of significantly different basicity. The imidazole nitrogen protonates first with a pKₐ of 6.8 for the conjugate acid, while the diketopiperazine nitrogen protonates with a pKₐ of 3.2. The isoelectric point occurs at pH 5.0. The protonation state significantly influences the electronic properties of the molecule, particularly the fluorescence quantum yield, which decreases by approximately 40% upon protonation of the imidazole nitrogen.

Redox properties include a reversible one-electron oxidation at +0.87 V versus the standard hydrogen electrode, corresponding to oxidation of the imidazole ring system. The reduction potential for the diketopiperazine carbonyl groups occurs at -1.35 V, making electrochemical reduction unlikely under physiological conditions. The compound demonstrates moderate antioxidant activity in radical scavenging assays with an EC₅₀ of 48 μM against the 2,2-diphenyl-1-picrylhydrazyl radical. This activity primarily results from hydrogen atom transfer from the imidazole N-H position with a bond dissociation energy of 87.5 kcal·mol⁻¹.

Synthesis and Preparation Methods

Laboratory Synthesis Routes

The total asymmetric synthesis of (-)-aurantiamine has been achieved through a convergent strategy combining L-histidine-derived precursors with appropriately functionalized diketopiperazine intermediates. The synthetic approach begins with N-Boc-protected L-histidine methyl ester, which undergoes regioselective alkylation at the imidazole ring using 1-bromo-2-methylbut-3-en-2-ene in the presence of sodium hydride in dimethylformamide at 0 °C with 75% yield. Subsequent deprotection and condensation with N-isopropyl-L-asparagine ethyl ester affords a linear peptide that undergoes cyclization under mild basic conditions (triethylamine in dichloromethane) to form the diketopiperazine ring with 68% yield.

The critical dehydrogenation step to introduce the exocyclic double bond employs 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) in toluene at reflux temperature, proceeding with 82% yield and complete stereoselectivity for the (Z)-isomer. Final deprotection and purification by preparative high-performance liquid chromatography (C18 column, methanol-water gradient) provides enantiomerically pure (-)-aurantiamine with overall yield of 32% from histidine starting material. The synthetic material exhibits identical spectroscopic properties and chiral rotation ([α]D²⁵ = -124°, c = 0.1 in methanol) to naturally isolated compound.

Analytical Methods and Characterization

Identification and Quantification

Chromatographic methods provide the primary means for aurantiamine identification and quantification. Reverse-phase high-performance liquid chromatography with C18 stationary phase and ultraviolet detection at 360 nm offers a reliable analytical method with retention time of 12.5 minutes using acetonitrile-water (65:35) mobile phase at 1.0 mL·min⁻¹ flow rate. The method demonstrates excellent linearity (R² = 0.9998) over the concentration range 0.1-100 μg·mL⁻¹ with a limit of detection of 0.03 μg·mL⁻¹ and limit of quantification of 0.1 μg·mL⁻¹.

Capillary electrophoresis with photodiode array detection provides an alternative separation method using 50 mM borate buffer at pH 9.2 with migration time of 8.2 minutes. Mass spectrometric detection in selected ion monitoring mode using electrospray ionization (m/z 303.2 for [M+H]⁺) offers enhanced specificity for complex biological matrices with detection limits below 5 ng·mL⁻¹. Chiral separation methods confirm enantiomeric purity using chiral stationary phases such as cellulose tris(3,5-dimethylphenylcarbamate) with hexane-isopropanol (80:20) mobile phase.

Applications and Uses

Research Applications and Emerging Uses

Aurantiamine serves primarily as a research tool in chemical biology and medicinal chemistry studies investigating structure-activity relationships within the diketopiperazine class of microtubule-binding agents. Its moderate biological activity, approximately 40-fold less potent than the closely related phenylahistin, makes it valuable for probing the structural requirements for interaction with tubulin and other cellular targets. Research applications include use as a lead compound for derivative synthesis, particularly modifications at the imidazole ring and variation of the alkyl substituents on the diketopiperazine ring.

Emerging applications exploit the compound's fluorescent properties for development of molecular probes. The blue fluorescence with large Stokes shift (80 nm) enables potential use as a fluorescent tag for biological imaging applications. Structural modifications focusing on enhancing fluorescence quantum yield (currently 0.32 in methanol) and shifting emission wavelengths are active areas of investigation. The compound's ability to cross biological membranes makes it particularly interesting for development of intracellular probes. Patent literature discloses aurantiamine derivatives as potential imaging agents for microtubule networks in living cells.

Historical Development and Discovery

Aurantiamine was first isolated and characterized in 1992 from cultures of Penicillium aurantiogriseum during systematic investigations of fungal metabolites in cereal contaminants. Initial structural elucidation employed extensive nuclear magnetic resonance spectroscopy and mass spectrometry, establishing the connectivity and relative stereochemistry. The absolute configuration was determined through chemical correlation with L-amino acid precursors and later confirmed by asymmetric total synthesis reported in 1998. The discovery contributed significantly to understanding the structural diversity of fungal diketopiperazines and their biological activities.

Historical development of aurantiamine chemistry parallels advances in natural product isolation techniques and asymmetric synthesis methodologies. Early studies focused on isolation and structural characterization, while subsequent research emphasized synthetic access and biological evaluation. The compound's identification as a structural analog of phenylahistin, a more potent microtubule binding agent, stimulated investigations into the structural requirements for biological activity within this compound class. Recent synthetic efforts have focused on improving overall yield and developing efficient routes to structural analogs for structure-activity relationship studies.

Conclusion

Aurantiamine represents a structurally complex diketopiperazine alkaloid with interesting chemical and spectroscopic properties. Its molecular architecture combines imidazole and diketopiperazine ring systems through an exocyclic double bond with defined stereochemistry, creating a conjugated system responsible for its characteristic blue fluorescence. The compound demonstrates moderate biological activity as a microtubule binding agent, though significantly less potent than close structural analogs. Successful asymmetric synthesis has provided access to enantiomerically pure material for detailed structure-activity relationship studies. Future research directions include development of enhanced synthetic methodologies, structural modification to improve biological activity and fluorescence properties, and application as a molecular probe for chemical biology investigations. The compound continues to serve as a valuable template for exploring the chemistry and biological activities of complex heterocyclic natural products.